Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Safety and Pharmacokinetics of Repeat Dosing of Long-Acting SARS-CoV-2 Antibodies Tixagevimab/Cilgavimab (AZD7442): Results from the PROVENT Sub-study.
Journal: Clinical drug investigation
Published: April 23, 2025
A phase 3b, multicenter, open-label, single-arm study of roxadustat (ASPEN): Operational learnings within United States dialysis organizations.
Journal: Hemodialysis international. International Symposium on Home Hemodialysis
Published: January 10, 2023
Showing 1-2 of 2
Last Updated: 09/26/2026